The pharmaceutical company poniard has developed the drug picoplatine for the treatment of small cell lung cancer (SCLC).The drug is in phase 3 clinical trials and data from its Phase III SPEAR trial is to be announced soon.This is a very promising step, a drug that reaches phase will see its self on the shelf in 2 to 3 years pending any further verification by regulatory agencies like the FDA or MHRA.
The drug has also been in phase 2 clinical trials for treatment in colorectal and prostate cancer and the results look promising...(Watch this space is all i have to say)
Reference
http://www.fiercebiotech.com/special-reports/five-biotech-companies-watch
No comments:
Post a Comment